Pico Interactive, the global developer of innovative virtual reality (VR) and enterprise solutions, has announced that the VR company REACT Neuro, will use the VR headset Pico Neo 2 Eye, with built-in Tobii Eye Tracking, to analyze brain health.
REACT Neuro will provide brain health analytics within physical therapy, sports medicine, senior living and the military. This technology is already being tested in different fields, from senior living to physical therapy. Asbury Methodist Village, a senior living community in Gaithersburg, Maryland, began using REACT Neuro in January 2021.
The Tobii Eye Tracking technology built into the Neo 2 Eye headset leverages dynamic foveated rendering, powered by Tobii Spotlight Technology™, to enhance the headset’s performance and create an optimal user experience in VR, based on where a user is looking. Building on the Pico Neo 2 Eye, REACT Neuro also uses Tobii Ocumen, a premium eye tracking solution, to develop new innovative features for their brain health platform.
If you want to know more about Tobii’s VR & AR offering, please visit: Tobii VR | Eye Tracking Technology in Virtual Reality
Anders Lundin, Corporate Communications Manager, Tobii Group, phone: +46 (0)733 27 87 61, email: firstname.lastname@example.org
Tobii is the global leader in eye tracking. Our mission is to improve the world with technology that understands human attention and intent. Tobii operates through three divisions: Tobii Dynavox, Tobii Pro and Tobii Tech. Tobii is headquartered in Sweden and is listed on Nasdaq Stockholm (TOBII). The group has over 1,000 employees. For more information: www.tobii.com.